•
Dec 31, 2023

iTeos Therapeutics Q4 2023 Earnings Report

Total Revenue
$0
Previous year: $53.9K
-100.0%
EPS
-$0.85
Previous year: $0.54
-257.4%
Gross Profit
-$233K
Previous year: $53.7M
-100.4%
Cash and Equivalents
$532M
Previous year: $285M
+86.8%
Free Cash Flow
-$15.2M
Previous year: -$27.3M
-44.4%
Total Assets
$668M
Previous year: $755M
-11.6%

iTeos Therapeutics

iTeos Therapeutics